Navigation Links
What price for a more effective health care system?
Date:6/26/2008

The pressures from an ageing population on the rising costs of healthcare in Australia will be the subject of the third annual Menzies Oration to be held at The Australian National University tonight.

Mr Gary Banks AO, Chairman of the Productivity Commission, will discuss the escalating budgetary pressures governments face from the increase in healthcare demand and costs at the public lecture to be held in the Finkel Lecture theatre at 5pm.

Mr Banks will suggest there is potential to raise productivity and reduce costs through policy initiatives in a number of areas of healthcare. A more cost-effective health system, rather than merely cost containment, must be the objective, he will argue.

The annual Menzies Oration aims to encourage open public debate on key health policy issues in Australia. It is presented by The Menzies Centre for Health Policy and Practice, a collaborative undertaking between The Australian National University and the University of Sydney.

The Centre was established in 2006 by a grant from the Sir Robert Menzies Memorial Foundation and aims to provide Australians with a better understanding of their health system and what it provides.

"Our aim is to bring independent, informed and balanced debate into Australia's health policy," says Co-Director of the Centre and Executive Director of ANU College of Medicine and Health Sciences Mr Robert Wells.

"We provide information to Australians about how they can influence health policy to ensure that it is consistent with their values and priorities and is able to deliver safe, high quality health care that is sustainable in the long term," he said.


'/>"/>

Contact: Penny Cox
Penny.Cox@anu.edu.au
61-261-253-549
Research Australia
Source:Eurekalert

Page: 1

Related medicine news :

1. Cataract Surgery: A Bargain, Despite the Price
2. Albemarle to Increase Price of Ibuprofen
3. PCMA Statement on New Average Manufacturer Price (AMP) Legislation
4. Pricey Running Shoes Not Worth It: Study
5. AHF Challenges Merck Over Steep Price of Its New AIDS Drug, Isentress
6. Canadians welcome HPV vaccine -- but not at any price
7. Lincare Holdings Inc. Prices $500 Million Convertible Senior Debentures Offering
8. Solae Announces Global Price Increase for Soy Protein Ingredients
9. Hagens Berman Sobol Shapiro: Judge Orders Double Damages, Issues Stinging Rebuke in Average Wholesale Price Case
10. AstraZeneca Response to November 2, 2007 Ruling In Re: Pharmaceutical Industry Average Wholesale Price Litigation, MDL No. 1456, U.S. District Court, District of Massachusetts
11. American Association for Homecare Disputes Validity of Internet Power Wheelchair Prices as Basis for Reimbursement of Services in Medicare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... experts advise , , SATURDAY, Dec. 5 (HealthDay News) -- ... can have bad reactions to certain holiday traditions and ... wheezing, according to the American College of Allergy, Asthma ... live evergreens may choose to decorate with artificial plants, ...
(Date:12/5/2009)... their cleaning processes. The technology available to the lab allows it ... customers relating to cleaning parts, process development, and verification. , ... ... a Jackson, MI-based company, is home to an advanced technology center ...
(Date:12/5/2009)... is a collaborative effort by the National Association ... North America (MANA), Citizens for Midwifery (CfM), International ... of Midwives (NARM), and the Midwifery Education Accreditation ... efforts of The MAMA Campaign to secure federal ...
(Date:12/4/2009)... Dec. 4 Varian Medical Systems (NYSE: VAR ... the regular 2010 Annual Meeting of Stockholders for February 11, ... meeting will be held at the Crowne Plaza Cabana Hotel, ... PT. ,, The meeting will be webcast by Thomson Financial ...
(Date:12/4/2009)... 4 Thousands of KPMG LLP employees came together in ... community service event which combines the audit, tax and advisory ... national service day reflects our firm,s long history of volunteerism. ... of caring to brighten the holidays for some children," said ...
Breaking Medicine News(10 mins):Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 2Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 4Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2
... characteristics help fine-tune treatment, study says , , FRIDAY, Dec. ... predicting breast cancer risk, recurrence risk and response to ... density and tumor size, a panel of experts report. ... Friday at the annual San Antonio Breast Cancer Symposium ...
... [The Washington Post Friday reported that the ... the White House are considering easing the official advisory cautioning ... at the Environmental Protection Agency reportedly are concerned about the ... of several "midnight" rules and policy changes in the pipeline ...
... Dec. 12 Roberta Kalafut, D.O., just announced her resignation ... a close the worst abuses of power by the TMB ... disciplinary actions, particularly against her competitors, and stonewalling by the ... "We applaud Kalafut,s resignation," said AAPS Executive Director ...
... climes becoming more conducive to spread , , FRIDAY, Dec. ... risk for infection with so-called "airport malaria" in malaria-free ... , Here,s how it happens, as the scientists explain ... tropical regions, and at the end of a flight ...
... to consumer-directed plan , , ... to make the most of their money, particularly their health ... 2.0, which helps members manage costs and still keep the ... a high-deductible plan with a health savings account (HSA). This ...
... , SAN ANTONIO, TEXAS - Early-stage breast cancer patients ... significant risk of recurrence of their disease, compared to those ... according to a study led by researchers at The University ... presented today at the CRTC-AACR San Antonio Breast Cancer Symposium, ...
Other Medicine News:Health News:Progress Made in Predicting Breast Cancer Risk 2Health News:Progress Made in Predicting Breast Cancer Risk 3Health News:AAPS Applauds the Resignation of TMB President Roberta Kalafut, Mari Robinson Should Resign Next 2Health News:'Airport Malaria' Risk Rising With Global Warming 2Health News:'Airport Malaria' Risk Rising With Global Warming 3Health News:Regence Unveils New Approach to Healthcare With Launch of HSA Healthplan 2.0 2Health News:Early stage, HER2-positive breast cancer patients at increased risk of recurrence 2Health News:Early stage, HER2-positive breast cancer patients at increased risk of recurrence 3
(Date:12/4/2009)... Suneva Medical, a privately-held aesthetic medical device company, ... President and Chief Financial Officer. In this role, ... administrative functions including finance, accounting, IT, IR, administration and ... Company,s senior management team. ,, "One of my ...
(Date:12/4/2009)... Shore and E. David Crawford presented results for prostate-specific ... end points of biochemical recurrence rate in a Phase ... or monthly leuprolide in prostate cancer patients during the ... received FIRMAGON 240/80 mg/month had a recurrence rate of ...
(Date:12/3/2009)... ACTON, Mass., Dec. 3 Allen Medical Systems, a ... ), today announced the launch of its new Allen ... www.AllenAmatech.com . ,, The website reinforces the ... of the new product catalog, with detailed descriptions and ...
Breaking Medicine Technology:Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2EHE International Supports the National Headache Foundation 48180 1EHE International Supports the National Headache Foundation 48180 2Quest Diagnostics to Speak at the William Blair 26 Company 29th Annual Growth Stock Conference 48179 1Quest Diagnostics to Speak at the William Blair 26 Company 29th Annual Growth Stock Conference 48179 2Senetek PLC Gains Six Year Extension of Rights from Czech Republic Institute of Experimental Botany 48177 1Senetek PLC Gains Six Year Extension of Rights from Czech Republic Institute of Experimental Botany 48177 2Senetek PLC Gains Six Year Extension of Rights from Czech Republic Institute of Experimental Botany 48177 3
... Complete Remission / Unconfirmed Complete Remission Rate 3.5 Fold Higher ... Compared to ... (Nasdaq and MTA: CTIC) announced today that it achieved the ... pixantrone,(BBR2778) for patients with advanced, relapsed aggressive non-Hodgkin,s,lymphoma (NHL) based ...
... Demonstrate Test,s Potential for ... Rapid Uptake, ... Applied Biosystems Inc. (NYSE: ABI ) today,announced the launch of BCtect(TM), ... a unique gene expression signature,identified by DiaGenic using a custom TaqMan(R) Array ...
Other Medicine Technology:Cell Therapeutics' Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint 2Cell Therapeutics' Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint 3Cell Therapeutics' Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint 4Diagenic Announces Launch of First Breast Cancer Gene-Expression Blood Test 2Diagenic Announces Launch of First Breast Cancer Gene-Expression Blood Test 3